Table 4.
(N) | FVCsup (mL) | ||||
---|---|---|---|---|---|
Initial | Follow up | Δ (%) | p | ||
Intra group | Inter group | ||||
Total (104) | 300.2 ± 145.4 | 385.6 ± 145.7 | 85.4 ± 82.9 (63.4) | <0.001** | |
Level of injury | |||||
Tetraplegia (65) | 266.9 ± 136.8 | 355.2 ± 137.5 | 88.3 ± 78.9 (82.1) | <0.001** | 0.003†† |
Paraplegia (39) | 355.8 ± 144.0 | 436.2 ± 146.7 | 80.4 ± 90.0 (32.1) | <0.001** | |
Injury severity | |||||
Complete (21) | 285.7 ± 140.0 | 366.7 ± 150.2 | 81.0 ± 69.0 (35.7) | <0.001** | 0.653 |
Incomplete (83) | 303.9 ± 147.4 | 390.4 ± 145.1 | 86.5 ± 86.4 (70.4) | <0.001** | |
Disease duration | |||||
Acute (14) | 347.1 ± 136.1 | 388.6 ± 136.0 | 41.4 ± 53.9 (14.9) | <0.001** | 0.004†† |
Subacute (45) | 284.6 ± 150.0 | 398.0 ± 157.8 | 113.4 ± 94.8 (104.8) | <0.001** | |
Chronic (45) | 301.3 ± 143.4 | 372.3 ± 137.9 | 70.9 ± 67.9 (37.0) | <0.001** |
Values are mean ± standard deviation.
**p < 0.01 by paired t test, ††p < 0.01 by Wilcoxon test.
PCF, peak cough flow; %ΔPCF, percent change of peak cough flow; L/min, litre per minute.